168 related articles for article (PubMed ID: 34333834)
1. The miRNAs involved in prostate cancer chemotherapy response as chemoresistance and chemosensitivity predictors.
Konoshenko M; Laktionov P
Andrology; 2022 Jan; 10(1):51-71. PubMed ID: 34333834
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin.
Konoshenko M; Lansukhay Y; Krasilnikov S; Laktionov P
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886942
[TBL] [Abstract][Full Text] [Related]
3. MiRNAs and radical prostatectomy: Current data, bioinformatic analysis and utility as predictors of tumour relapse.
Konoshenko MY; Laktionov PP
Andrology; 2021 Jul; 9(4):1092-1107. PubMed ID: 33638886
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer therapy outcome prediction: are miRNAs a suitable guide for therapeutic decisions?
Konoshenko M; Laktionov P; Bryzgunova O
Andrology; 2024 May; 12(4):705-718. PubMed ID: 37750354
[TBL] [Abstract][Full Text] [Related]
5. miRNAs and radiotherapy response in prostate cancer.
Konoshenko MY; Bryzgunova OE; Laktionov PP
Andrology; 2021 Mar; 9(2):529-545. PubMed ID: 33053272
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.
Matuszcak C; Haier J; Hummel R; Lindner K
World J Gastroenterol; 2014 Oct; 20(38):13658-66. PubMed ID: 25320504
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
9. miRNA as Regulators of Prostate Carcinogenesis and Endocrine and Chemoresistance.
Culig Z
Curr Cancer Drug Targets; 2021; 21(4):283-288. PubMed ID: 33423646
[TBL] [Abstract][Full Text] [Related]
10. Exosome-derived microRNAs contribute to prostate cancer chemoresistance.
Li J; Yang X; Guan H; Mizokami A; Keller ET; Xu X; Liu X; Tan J; Hu L; Lu Y; Zhang J
Int J Oncol; 2016 Aug; 49(2):838-46. PubMed ID: 27278879
[TBL] [Abstract][Full Text] [Related]
11. Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway.
Singh S; Chitkara D; Mehrazin R; Behrman SW; Wake RW; Mahato RI
PLoS One; 2012; 7(6):e40021. PubMed ID: 22768203
[TBL] [Abstract][Full Text] [Related]
12. miRNAs and androgen deprivation therapy for prostate cancer.
Konoshenko MY; Bryzgunova OE; Laktionov PP
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188625. PubMed ID: 34534639
[TBL] [Abstract][Full Text] [Related]
13. Screening candidate microRNA-mRNA network for predicting the response to chemoresistance in osteosarcoma by bioinformatics analysis.
Dai P; He Y; Luo G; Deng J; Jiang N; Fang T; Li Y; Cheng Y
J Cell Biochem; 2019 Oct; 120(10):16798-16810. PubMed ID: 31090103
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
Wang YW; Zhang W; Ma R
Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-guided gene expression in prostate cancer: Literature and database overview.
Bryzgunova OE; Konoshenko MY; Laktionov PP
J Gene Med; 2018 May; 20(5):e3016. PubMed ID: 29578262
[TBL] [Abstract][Full Text] [Related]
16. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
[TBL] [Abstract][Full Text] [Related]
17. The Roles of microRNAs in Regulating Chemotherapy Resistance of Non-Small Cell Lung Cancer.
Wei X; Shen X; Ren Y; Hu W
Curr Pharm Des; 2018 Feb; 23(39):5983-5988. PubMed ID: 29046142
[TBL] [Abstract][Full Text] [Related]
18. Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis.
Ma H; Wang LY; Yang RH; Zhou Y; Zhou P; Kong L
J Cell Biochem; 2019 Oct; 120(10):17779-17790. PubMed ID: 31127646
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs.
Rizzo M
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188481. PubMed ID: 33217485
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer.
Zhu W; Shao Y; Peng Y
Mol Carcinog; 2017 Jun; 56(6):1570-1577. PubMed ID: 28052414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]